Investment analysts at StockNews.com began coverage on shares of Amarin (NASDAQ:AMRN – Get Free Report) in a research note issued on Sunday. The firm set a “sell” rating on the biopharmaceutical ...

Fidelity is one of the most well-rounded brokerages available today. It offers no commissions on stock or ETF trades and a selection of no-expense-ratio index funds suited to both beginner and ...